BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21638518)

  • 1. The DNA methylome of benign and malignant parathyroid tumors.
    Starker LF; Svedlund J; Udelsman R; Dralle H; Akerström G; Westin G; Lifton RP; Björklund P; Carling T
    Genes Chromosomes Cancer; 2011 Sep; 50(9):735-45. PubMed ID: 21638518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
    Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
    Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global and gene-specific promoter methylation analysis in primary hyperparathyroidism.
    Sulaiman L; Juhlin CC; Nilsson IL; Fotouhi O; Larsson C; Hashemi J
    Epigenetics; 2013 Jun; 8(6):646-55. PubMed ID: 23764768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.
    Singh P; Bhadada SK; Dahiya D; Arya AK; Saikia UN; Sachdeva N; Kaur J; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2020 Sep; 105(9):3015-24. PubMed ID: 32609827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas.
    Arya AK; Bhadada SK; Singh P; Sachdeva N; Saikia UN; Dahiya D; Behera A; Bhansali A; Rao SD
    Sci Rep; 2017 Jun; 7(1):3123. PubMed ID: 28600574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma.
    Hewitt KM; Sharma PK; Samowitz W; Hobbs M
    Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):928-33. PubMed ID: 18217513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
    Sulaiman L; Haglund F; Hashemi J; Obara T; Nordenström J; Larsson C; Juhlin CC
    PLoS One; 2012; 7(9):e46325. PubMed ID: 23029479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
    Singh P; Bhadada SK; Dahiya D; Saikia UN; Arya AK; Sachdeva N; Kaur J; Behera A; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4084-e4096. PubMed ID: 34077544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification.
    Svedlund J; Koskinen Edblom S; Marquez VE; Åkerström G; Björklund P; Westin G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1307-15. PubMed ID: 22544915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypermethylation and regulation of expression of secreted frizzled-related protein genes in colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH; Zhang JM
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):842-5. PubMed ID: 18396643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis.
    Singh P; Bhadada SK; Arya AK; Saikia UN; Sachdeva N; Dahiya D; Kaur J; Brandi ML; Rao SD
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e783-e792. PubMed ID: 34453169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
    Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
    PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
    Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas.
    Oster B; Thorsen K; Lamy P; Wojdacz TK; Hansen LL; Birkenkamp-Demtröder K; Sørensen KD; Laurberg S; Orntoft TF; Andersen CL
    Int J Cancer; 2011 Dec; 129(12):2855-66. PubMed ID: 21400501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability.
    Muto Y; Maeda T; Suzuki K; Kato T; Watanabe F; Kamiyama H; Saito M; Koizumi K; Miyaki Y; Konishi F; Alonso S; Perucho M; Rikiyama T
    BMC Cancer; 2014 Jun; 14():466. PubMed ID: 24964857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
    Sanpaolo E; Miroballo M; Corbetta S; Verdelli C; Baorda F; Balsamo T; Graziano P; Fabrizio FP; Cinque L; Scillitani A; Muscarella LA; Guarnieri V
    Endocrine; 2016 Oct; 54(1):55-59. PubMed ID: 26876532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.
    Lind GE; Kleivi K; Meling GI; Teixeira MR; Thiis-Evensen E; Rognum TO; Lothe RA
    Cell Oncol; 2006; 28(5-6):259-72. PubMed ID: 17167179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.